Skip to main content
SpringerLink
Log in

Immunization with Dendritic Cells Pulsed with Tumor Extract Increases Survival of Mice Bearing Intracranial Gliomas

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

The purpose of this study is to investigate the efficacy of dendritic cell-mediated immunotherapy against intracranial gliomas. Cloned DC2.4 dendritic cells originating from C57BL/6 mice were pulsed with glioma GL261 cell extracts and administered i.p. to C57BL/6 mice with intracranial GL261 gliomas. The survival of mice with and without pulsed dendritic cells was monitored after intracranial implantation of the GL261 glioma cells. Fluorescence activated cell sorting (FACS) analysis showed that DC2.4 cells express high levels of MHC class I and class II molecules, costimulatory molecules B7-l and B7-2, and the cell adhesion molecule ICAM-l. Antigen-presenting capabilities in these dendritic cells were initially characterized in vitro by a mixed lymphocyte reaction, showing that Balb/c CD4+ and CD8+ T cells were able to generate allogeneic responses to DC2.4 cells. Tumor extract-pulsed DC2.4 dendritic cells were then used for the treatment of C57BL/6 mice with syngeneic GL261 gliomas. Animals with intracranial GL261 gliomas and vaccinated i.p. with pulsed DC2.4 dendritic cells exhibited significantly enhanced survival, relative to animals treated with saline or non-pulsed DC2.4 cells alone. In addition, cured animals showed an increased delayed-type hypersensitivity response to GL261 cells and survived when rechallenged with intracranial GL261 gliomas. In summary these results indicate that dendritic cells pulsed with tumor extract can enhance immune responses to tumor antigen and therefore represent a potential immunotherapeutic approach for treating patients with intracranial gliomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Parney IF, Hao C, Petruk KC: Glioma immunology and immunotherapy. Neurosurg 46: 778–792, 2000

    Google Scholar 

  2. Roszman T, Elliott I, Brooks W: Modeulation of T cell function by gliomas. Immunol Today 12: 370–374, 1991

    Google Scholar 

  3. Chi DD, Merchant RE, Rand R, Conrad AJ, Garrison D, Turner R, Norton DL, Hoon DSB: Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas. Amer J Pathol 150: 2143–2152, 1997

    Google Scholar 

  4. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9: 271–296, 1991

    Google Scholar 

  5. Dummer W, Becker JC, Schwaaf A, Leverkus M, Moll T, Brocker EB: Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma. Melanoma Res 6: 67–68, 1995

    Google Scholar 

  6. Caux C, Liu Y, Banchereau J: Recent advances in the study of dendritic cells and follicular dendritic cells. Immunol Today 16: 2–6, 1995

    Google Scholar 

  7. Gabrilovich DI, Chen HI, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Javanaugh D, Carbone DP: Production of vascular endotheial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature Med 2: 1096–1103, 1996

    Google Scholar 

  8. Steinman R: The dendritic cells system and its role in immunogenicity. Ann Rev Immunol 9: 271–296, 1991

    Google Scholar 

  9. Chen Q, Daniel V, Maher DW, Hersey P: Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma. Int J Cancer 56: 755–760, 1994

    Google Scholar 

  10. Chaux P, Favre N, Bonnotte B, Moutet M, Martin M, Martin F: Tumor infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression. Fund Clin Immunol 525–528, 1997

  11. Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD Jr.: Peptide-pulsed dendritic cells induce antigenspecific CTL-mediated protective tumor immunity. J Exp Med 183: 283–287, 1996

    Google Scholar 

  12. Specht JM, Wang G, Do MT, Lam JS, Royal RE, Reeves ME, Rosenberg SA. Hwu P: Dendritic cells retrovirally transduced with model tumor antigen gene are therapeutically effective against established pulmonary metastases. J Exp Med 186: 1213–1221, 1997

    Google Scholar 

  13. Young JW, Inaba K: Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J Exp Med 183: 7–11, 1996

    Google Scholar 

  14. Nair SK, Snyder BT, Rouse BT, Gilboa E: Regression of tumors in mice vaccined with professional antigenpresenting cells pulsed with tumor extracts. Int J Cancer 70: 706–715, 1997

    Google Scholar 

  15. Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, Burg G, Schadendorf D: Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nature Med 4: 328–332, 1998

    Google Scholar 

  16. Chen Z, Reznikoff, Dranoff G, Rock KL: Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 158: 2723–2730, 1997

    Google Scholar 

  17. Coligan JE, Kruisbeek A, Margulies D, Shevach E, Strober W: Curr Prot Immunol, 1992

  18. Zorina T: Culture od dendritic cells from murine bone marrow supplemented with GM-CSF and TNF-alpha. J Immunother 16: 247–258, 1994

    Google Scholar 

  19. Inaba K: eneration of large numbers of dendritic cells from mouse bone marrow cultures supplemented with GM-CSF. J Exp Med 176: 1693–1702, 1992

    Google Scholar 

  20. Inaba K, Steinman RM, Witmer-Pack M, Aya H, Inaba M, Sudo T, Wolpe S, Schuler G: Identification of proliferating 9 dendritic cells precursors in mouse blood. J Exp Med 175: 1157–1164, 1992

    Google Scholar 

  21. Lu L, Woo J, Rao AS, Li Y, Watkins SC, Qian S, Starzl TE, Demetris AJ, Thompson AW: Propagation of dendritic cell progenitors from normal mouse liver using GMC-SF and their maturational development in the presence of type-I collagen. J Exp Med 179: 1823–1834, 1994

    Google Scholar 

  22. Schuler G, Steinman RM: Murine epidermal langerhans cell mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 161: 526–546, 1985

    Google Scholar 

  23. Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trochenbacher B, Konwalinka G, Gritsch PO, Steinman RM, Schuler G: Proliferation dendritic cell progenitors in human blood. J Exp Med 180: 83–93, 1994

    Google Scholar 

  24. Zitvogel L, Mayordomo JI, Tjandrawan T, Deleo AB, Clarke MR, Lotze MT, Storkus WJ: Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 183: 87–97, 1996

    Google Scholar 

  25. Nair SK, Boczkowski D, Snyder D, Gilboa E: Antigenpresenting cells pulsed with unfractionated tumor-derived peptides are potent tumor vaccines. Eur J Immunol 27: 589–597, 1997

    Google Scholar 

  26. Liau L, Black KL, Prins RM. Sykes SN, Dipatre PL, Cloughesy TF, Becker DP, Bronstein JM: Treatment of intracranial gliomas with bone marrow derived dendritic cells pulsed with tumor antigens. J Neurosurg 90: 1115–1124, 1999

    Google Scholar 

  27. Heufler C, Koch F. Stanzl U: Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol 26: 659–668, 1996

    Google Scholar 

  28. Kanangat S, Nair S, Babu JS, Rouse BT: Expression of cytokine mRNA in murine splenic dendritic cells and better induction of T cell-derived cytokines by dendritic cells than macrophages during in vitro costimulation assay using specific antigens. J Leukoc Biol 57: 310–316, 1995

    Google Scholar 

  29. Macatonia SE, Hosken NA, Litton M: Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4 T cells. J Immunol 154: 5071–5079, 1995

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, University of Minnesota, Minneapolis, MN, USA

    Hsiao-Tzu Ni, Walter C. Jean & Walter A. Hall

  2. Department of Therapeutic Radiology, University of Minnesota, Minneapolis, MN, USA

    Stephen R. Spellman & Walter A. Hall

  3. Cancer Center, University of Minnesota, Minneapolis, MN, USA

    Walter A. Hall & Walter C. Low

  4. Program in Neuroscience, University of Minnesota, Minneapolis, MN, USA

    Walter C. Low

Authors
  1. Hsiao-Tzu Ni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen R. Spellman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Walter C. Jean
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Walter A. Hall
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Walter C. Low
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ni, HT., Spellman, S.R., Jean, W.C. et al. Immunization with Dendritic Cells Pulsed with Tumor Extract Increases Survival of Mice Bearing Intracranial Gliomas. J Neurooncol 51, 1–9 (2001). https://doi.org/10.1023/A:1006452726391

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006452726391

Search

Navigation